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We test the hypothesis that the translation machinery in cells infected by influenza A virus efficiently translates only
mRNAs that possess the influenza viral 59 untranslated region (59-UTR) by introducing mRNAs directly into the cytoplasm of
infected cells. This strategy avoids effects due to the inhibition of the nuclear export of cellular mRNAs mediated by the viral
NS1 protein. In one approach, we transfect in vitro synthesized mRNAs into infected cells and demonstrate that these
mRNAs are efficiently translated whether or not they possess the influenza viral 59-UTR. In the second approach, an mRNA
is synthesized endogenously in the cytoplasm of influenza A virus infected cells by a constitutively expressed T7 RNA
polymerase. Although this mRNA is uncapped and lacks the influenza viral 59-UTR sequence, it is efficiently translated in
infected cells via an internal ribosome entry site. We conclude that the translation machinery in influenza A virus infected
cells is capable of efficiently translating all mRNAs and that the switch from cellular to virus-specific protein synthesis that
occurs during infection results from other processes. © 2001 Academic Press
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oIntroduction. After infection of cells by influenza A
virus, a dramatic switch from cellular to viral protein
synthesis occurs (reviewed in Ref. 1). The vast majority of
the cellular mRNAs in the cytoplasm of infected cells is
synthesized prior to infection, and the inhibition of the
translation of these “old” cellular mRNAs and their deg-
radation during virus infection likely plays a large role in
the switch from cellular to viral protein synthesis (2–5). In
contrast, the inhibition of the nuclear export of newly
synthesized cellular mRNAs via the action of the viral
NS1 protein (6–8) and the ensuing nuclear degradation
of the sequestered cellular mRNAs (9) does not appear
to play a significant role in the translational switch (5).
It has also been proposed that the switch to viral
protein synthesis is mediated by an additional mecha-
nism: after infection by influenza A virus, only those
mRNAs containing the viral 59-untranslated region (UTR)
that is present on all viral mRNAs can be translated
efficiently (10, 11). The experiments in support of this
roposal were carried out in the early 1990s and em-
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180loyed a transfection–infection strategy. COS-1 cells
ere transfected with a DNA plasmid that replicates in
hese cells and that encodes a cellular or viral mRNA
equence, and 39 h later the cells were either mock-
nfected or infected with influenza A virus for up to 5 h.
uring the time that the steady state level of the cellular
nd viral mRNA species did not decrease during influ-
nza virus infection, the only mRNAs that were translated
n infected cells were those that contained the viral
9-UTR. The interpretation of this result was that efficient
ranslation in influenza A virus infected cells requires
hat an mRNA contain the viral 59-UTR (11, 12). However,
s documented in the present study, this interpretation
annot be substantiated by experimental approaches,
hich avoid the complications caused by the inhibition of
he nuclear export of cellular mRNAs that occur during
nfection. These new experimental approaches show
hat mRNAs in the cytoplasm of influenza A virus infected
ells are efficiently translated whether or not they have
he viral 59-UTR.
Results and Discussion. Our strategy for determining
he role of the 59 viral UTR in translation in influenza A
irus infected cells was to introduce mRNAs into the
ytoplasm during virus infection without the involvement
f nuclear events, thereby avoiding effects due to thenhibition of the nuclear export of cellular mRNAs that is
ediated by the viral NS1 protein (6–8). As an initial
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181RAPID COMMUNICATIONapproach, we superinfected influenza virus-infected
HeLa cells at 4 h postinfection with vaccinia virus, which
synthesizes its mRNAs in the cytoplasm (reviewed in Ref.
12). At 4 h after influenza virus infection, influenza virus-
specific proteins were synthesized at high levels, and
cellular protein synthesis was effectively shutdown (Fig.
1, compare lanes 5 and 2). In contrast to cellular protein
synthesis, vaccinia virus specific proteins were effi-
ciently synthesized after superinfection of influenza virus
infected cells at 4 h postinfection (lane 3). In addition,
vaccinia virus superinfection had little effect on the syn-
thesis of influenza virus specific proteins (lane 4). These
results indicate that influenza virus infection does not
inhibit the translation of vaccinia virus mRNAs which are
synthesized in the cytoplasm and can be interpreted in
two ways: (i) mRNAs that are synthesized in the cyto-
plasm of influenza virus infected cells are efficiently
translated even when they lack the influenza virus spe-
cific 59-UTR; or (ii) vaccinia virus establishes a separate
translational control system that enables its mRNAs to
be translated despite an influenza virus imposed block
against the translation of cellular mRNAs that lack the
influenza virus specific 59-UTR.
To distinguish between these two interpretations, we
took two approaches. In one approach, we transfected
specific mRNAs into influenza virus infected cells,
thereby enabling us to introduce any mRNA directly into
the cytoplasm of these cells. These mRNAs were syn-
thesized in vitro using T7 or SP6 RNA polymerase in the
presence of m7GpppGm. Transfection of an mRNA was
FIG. 1. Influenza virus infection does not inhibit the translation of v
vaccinia virus and collected at 6 h postinfection (V6, lane 1); or were i
or 10 h (F10, lane 4) postinfection; or were first infected with 20 PFU/
PFU/ml of vaccinia virus, and then collected 6 h later (F4/V6, lane 3). As
were labeled with [35S]methionine for 30 min prior to collection and lab
ositions of vaccinia viral and influenza viral proteins are denoted.arried out for 4 h, from 2 to 6 h after influenza virus
nfection. The efficiency of transfection was monitored byransfecting cells with an in vitro synthesized capped
RNA encoding green fluorescent protein (GFP). Fluo-
escence microscopy showed that approximately 40% of
he cells expressed GFP, indicating a high efficiency of
ransfection. Three mRNAs containing a luciferase open
eading frame (ORF) were transfected into influenza A
irus infected cells (Fig. 2A). All three mRNAs contain not
nly a 59 cap structure but also a 39 poly(A) sequence
hat is directly transcribed from a sequence in the plas-
id. In one mRNA (mRNA I) the firefly luciferase ORF is
lanked by the 59- and 39-UTRs from the globin mRNA of
enopus laevis. A second mRNA (mRNA II) has the 59
equence of the viral nucleocapsid protein (NP) mRNA: a
9 capped nonviral sequence of 11 nucleotides, which
orresponds to the capped sequence that is snatched
rom cellular pre-mRNAs by the viral cap-dependent en-
onuclease (reviewed in Ref. 1), followed by the 12 nu-
leotide 59-UTR that is common to all influenza viral
RNAs. The 59 viral UTR is followed by a sequence (32
ucleotides in length) that is specific for the viral NP
RNA, and the mRNA also contains the 39-UTR of the
iral NP mRNA. In the third mRNA (mRNA III), the se-
uence of the 59 viral UTR has been inverted (mutant
9-UTR).
Influenza A virus infected cells were collected 2 h after
ompletion of the mRNA transfection, i.e., at 8 h postin-
ection, and luciferase activity in an aliquot of the cell
xtracts was measured (Fig. 2B). A large increase in
uciferase activity resulted after transfection of 10 mg of
each mRNA, ranging from 15,000 to 28,000 relative light
virus specific mRNAs. HeLa cells were infected with 20 PFU/cell of
with 20 PFU/ml of influenza A virus and collected at 4 h (F4, lane 2),
fluenza virus, followed by superinfection at 4 h postinfection with 20
trol, cells were mock-infected and collected 6 h later (M, lane 6). Cells
oteins were analyzed by SDS–polyacrylamide gel electrophoresis. Theaccinia
nfected
ml of in
a conunits in several experiments, indicating that a substantial
amount of the luciferase protein was synthesized. Trans-
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182 RAPID COMMUNICATIONfection of the mRNA containing the globin 59-UTR (mRNA
I) consistently resulted in the highest level of luciferase
activity, at all levels of each mRNA that were transfected
into infected cells (0.3–10 mg). These results indicate that
n mRNA containing a nonviral 59-UTR can be translated
n influenza A virus infected cells even more efficiently
han an mRNA containing a viral 59-UTR. We also mea-
FIG. 2. The translation machinery in cells infected by influenza A vir
influenza viral 59UTR. (A) Structure of the three luciferase mRNAs that
three mRNAs in virus-infected cells. Ten micrograms of each of these
A virus infection. After replacement of the transfection reagent with cell c
activity in a 20 ml aliquot of the cell extract was determined. (C) The a
r II shown in A. Two hours after replacement of the transfection reage
lot analysis using three 32P-labeled oligonucleotides specific for lucife
uciferase protein synthesis by radiolabeling. Ten micrograms of mRN
nfluenza A virus infection. After replacement of the transfection reage
lane). As a control, nontransfected influenza A virus infected HeLa
abeled with [35S]methionine for 30 min prior to collection, and labele
positions of luciferase and of several influenza viral proteins are denoured the mRNA levels by Northern analysis (Fig. 2C),
lthough it was not possible to distinguish intracellular,unctional mRNAs from mRNAs that were bound to the
ell surface. All three mRNAs were consistently present
n approximately equivalent amounts (mRNA I is not
hown in Fig. 2C). Finally, using the most efficiently
ranslated mRNA (mRNA I), we measured the amount of
ewly synthesized luciferase protein by labeling cells for
0 min with [35S]methionine 2 h after completion of the
iently translates transfected mRNAs whether or not they possess the
ansfected into influenza A virus infected cells. (B) Translation of these
was transfected into HeLa cells for 4 h starting at 2 h after influenza
medium, the cells were collected 2 h later, and the amount of luciferase
of luciferase mRNA in infected cells transfected with 10 mg mRNAs I
cells were collected, and total cellular RNA was subjected to Northern
RNA. The position of luciferase mRNA is denoted. (D) Quantitation of
wn in A was transfected into HeLa cells for 4 h starting at 2 h after
cell culture medium, the cells were collected 2.5 h later (transfection
ere collected at 8.5 h postinfection (transfection 2 lane). Cells were
ins were analyzed by SDS–polyacrylamide gel electrophoresis. The
e identity of the luciferase protein was verified by Western analysis.us effic
were tr
mRNAs
ulture
mount
nt, the
rase m
A I sho
nt with
cells wmRNA transfection, i.e., between 8 and 8.5 h after influ-
enza A virus infection, and analyzing the labeled proteins
183RAPID COMMUNICATIONby gel electrophoresis (Fig. 2). The luciferase protein was
synthesized at a level approximating that of several viral
proteins, i.e., the three P protein subunits of the viral
polymerase, and viral protein synthesis was not affected
by transfection of the luciferase mRNA. Clearly, this
mRNA which lacks the viral 59-UTR is efficiently trans-
lated in influenza A virus infected cells.
In the second approach, mRNA was synthesized en-
dogenously in the cytoplasm of influenza A virus infected
cells. To accomplish such cytoplasmic mRNA synthesis,
we used BT7-H cells which constitutively express bac-
teriophage T7 RNA polymerase in the cytoplasm (13).
These cells were transfected with a plasmid encoding
the luciferase ORF under the control of the T7 promoter.
The luciferase ORF is preceded by an internal ribosome
entry site (IRES) from encephalomyocarditis virus
(EMCV) (14), which is efficiently utilized in BT7-H cells
(13). The resulting mRNA contains an uncapped, pppG 59
end and 458 nucleotides of the EMCV IRES upstream of
the luciferase ORF (Fig. 3A). After influenza A virus infec-
tion of BT7-H cells transfected with this plasmid, the
usual switch to virus-specific protein synthesis occurred
(data not shown). To determine whether the uncapped
luciferase mRNA was translated via its IRES after influ-
enza A virus infection, BT7-H cells at 24 h after transfec-
tion were infected with influenza A virus or mock-in-
fected, and luciferase activity was measured 2, 4, and 6 h
later. As shown in Fig. 3B, a large increase in luciferase
FIG. 3. Newly synthesized uncapped mRNAs lacking the viral 59-UTR
are efficiently translated via an IRES in the cytoplasm of influenza A
virus infected cells. (A) Structure of the 59 end of the luciferase mRNA
synthesized by T7 RNA polymerase in the cytoplasm of BT7-H cells. (B)
BT7-H cells were transfected with the plasmid encoding the IRES-
containing luciferase mRNA and 24 h later were infected with influenza
A virus or were mock-infected. At 2, 4, and 6 h postinfection or mock-
infection, the cells were collected, and the amount of luciferase activity
in a 20 ml aliquot of the cell extract was determined.activity occurred after influenza virus infection. In fact,
this increase was greater than that occurring after mockinfection, presumably due to the countermeasures
mounted by influenza virus against cellular antiviral re-
sponses (15). These results indicate that uncapped
mRNAs lacking the viral 59-UTR are efficiently translated
via an IRES in the cytoplasm of influenza A virus infected
cells.
By introducing mRNAs directly into the cytoplasm after
influenza A virus infection, we avoid the complications
resulting from the inhibition of the nuclear export of
cellular mRNAs that is mediated by the viral NS1 protein
(6–8). This is not the case for the transfection–infection
strategy employed in previous experiments carried out in
the early 1990s (10, 11). In these experiments the pre-
mRNAs, which were encoded by transfected replicating
DNA plasmids, were synthesized by cellular RNA poly-
merase II in the nucleus. However, most mRNAs that are
synthesized by cellular RNA polymerase II after influenza
A virus infection are not exported to the cytoplasm be-
cause their 39 end processing is inhibited by the viral
NS1 protein (6–8). In fact, most of the newly synthesized
cellular pre-mRNAs and mRNAs that are retained in the
nucleus are degraded (9). It is likely that this nuclear
degradation is initiated by the decapping of cellular pre-
mRNAs and mRNAs by the viral cap-dependent endonu-
clease (reviewed in Ref. 1), thereby rendering these
RNAs susceptible to degradation by the cellular 59–39
exoribonuclease(s) in the nucleus (16). However, it has
been shown that the viral 59-UTR sequence protects
pre-mRNAs and mRNAs from cleavage by the viral cap-
dependent endonuclease (17), so that capped pre-
mRNAs and mRNAs containing the viral 59-UTR would be
more stable than the decapped pre-mRNAs and mRNAs
lacking the viral 59-UTR. Hence, it is likely that mRNAs
synthesized by polymerase II that escape the inhibition
of 39 end processing and nuclear export would be com-
posed primarily of mRNAs containing the viral 59-UTR,
which would then be translated. Because the experi-
ments carried out in the early 1990s employed replicat-
ing plasmids (10, 11), large amounts of the encoded
pre-mRNAs would have been synthesized, thereby in-
creasing the likelihood that some of the mature mRNAs
would escape the inhibition of nuclear export. Thus,
these earlier results can be attributed to a nuclear func-
tion of the viral 59-UTR that was subsequently discov-
ered, i.e., protecting pre-mRNAs and mRNAs from cleav-
age by the viral cap-dependent endonuclease in the
nucleus (17).
We have demonstrated that the translation machinery
in the cytoplasm of cells infected by influenza A virus is
capable of efficiently translating mRNAs whether or not
they possess the influenza viral 59-UTR. In fact, we show
that this machinery can even efficiently initiate transla-
tion via the IRES of an uncapped mRNA that lacks the
influenza viral 59-UTR sequence. Because our experi-
ments have focused on mRNAs that appear in the cyto-
plasm after infection, our results indicate that any cellu-
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escape the NS1 protein-mediated block in nuclear export
would be translated in cells infected by influenza A virus.
In addition, our results indicate that the switch from
cellular to influenza viral protein synthesis results solely
from the inhibition of the translation of the cellular
mRNAs that are synthesized before infection (old cellular
mRNAs) and from the degradation of these cellular
mRNAs (2–5). A major challenge will be to elucidate how
influenza A virus infection causes these effects on old
cellular mRNAs.
Materials and Methods. Hela S3 cells were infected
with influenza A/WSN/33, or vaccinia virus WR strain, or
both viruses at a multiplicity of infection (m.o.i.) of 20
plaque-forming units (PFU) per cell.
Subconfluent 60 mm cultures of HeLa cells, at 2 h after
influenza A virus infection, were transfected with the
indicated amount of an mRNA using 30 ml Lipofectin
eagent (Gibco BRL). After 4 h of incubation, the trans-
ection reagent was removed and replaced with fresh
ell medium. The transfected mRNAs were transcribed in
itro from the following plasmids in the presence of
7GpppGm. The pBgLucBgAn plasmid (18) was tran-
scribed with T7 RNA polymerase after linearization with
PstI. The pNP-Luc-NP and pNPmut-Luc-NP plasmids
were linearized with Xmn1 and transcribed with SP6 RNA
polymerase to produce the two mRNAs used for the
experiment shown in Fig. 2B. The plasmid encoding GFP
mRNA (pGFP plasmid) was linearized with EcoRI and
transcribed with SP6 RNA polymerase to produce the
mRNA used to determine transfection efficiency. To con-
struct the pNP-Luc-NP plasmid, the pSP64Poly(A) plas-
mid (Promega), which was modified to contain an Xmn1
restriction site in place of an EcoRI site, was digested
with HindII and SacI, and the following three DNA se-
quences were then ligated into this linearized plasmid:
(1) the 59-UTR of influenza virus NP mRNA containing
HindII and NcoI ends, obtained by annealing two oligo-
nucleotides (48 and 51 nucleotides in length) of the
appropriate sequence; (2) the firefly luciferase ORF con-
taining NcoI and NotI ends; and (3) the 39-UTR of influ-
enza virus NP mRNA containing NotI and SacI ends,
obtained by annealing two oligonucleotides of the ap-
propriate sequence. For the construction of the pNPmut-
Luc-NP plasmid, DNA(1) was replaced with a DNA en-
coding the mutated form of the 59-UTR of the NP mRNA
and containing HindII and NcoI ends, obtained by an-
nealing two oligonucleotides of the appropriate se-
quence. To construct the pGFP plasmid, the pEGFP-1
plasmid (Clontech) was linearized with XbaI, which was
then blunt-ended using T4 DNA polymerase, and the
EGFP coding sequence was then excised by digestion
with BamHI. The EGFP coding sequence was then in-
serted into the pSP64poly(A) plasmid that had been lin-
earized by digestion with both BamHI and SmaI. To verifythese cloning strategies, the resulting plasmids were
sequenced.
Luciferase assays at the indicated times were carried
out using Promega luciferase assay reagents and a
Turner Designs Luminometer TD-20/20. In this assay,
luciferase activity in a 20 ml aliquot of the cell extract
(total volume of 250 ml) was measured. Luciferase mRNA
was detected by Northern analysis of total cellular RNA
using three 59 32P-labeled oligonucleotides that are com-
lementary to three different regions of luciferase mRNA.
A plasmid encoding luciferase mRNA under the con-
rol of the T7 promoter was constructed by ligating the
irefly ORF containing NcoI and XbaI ends into the pCITE
a(1) plasmid (Novagen) which had been digested with
hese two restriction enzymes. This plasmid was trans-
ected into BT7-H cells, which constitutively express bac-
eriophage T7 RNA polymerase (13), and at 24 h post-
ransfection the cells were infected with 20 PFU of influ-
nza A/WSN/33 virus, or mock-infected.
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